News Archive
2018
HTAi 2018 Annual Meeting in Vancouver / Canada, June 01 – 05, 2018
Now available for download: Poster presentations on “The Search for a Cost Effectiveness Standard: 1-3 Times GDP/Capita?” and “Social Preferences for Health Care Interventions: The SoPHI Study” at the HTAi 2018 Annual Meeting in Vancouver / Canada, June 01 - 05, 2018.
ISPOR 2018 International Conference in Baltimore, MD / United States, May 19 – 23, 2018
Now available for download: Poster presentations on “New Estimates of the Willingness-To-Pay for a Statistical Life Year: A Systematic Review of the Empirical Economic Literature” and “Should Rarity Matter? Results of a Social Willingness-To-Pay Study using the Discrete Choice Experiment (DCE) Method in Switzerland” at the ISPOR 2018 International Conference in Baltimore, MD / United States, May 19 - 23, 2018.
"Economical Perspectives in Rare Diseases" at the ECRD 2018 in Vienna / Austria, May 10 - 12, 2018
Michael Schlander was session chair and speaker on the subject "A Paradigm Shift in Value Frameworks for Access" as well as theme leader for "Economical Perspectives in Rare Diseases" at the 9th European Conference on Rare Diseases & Orphan Products (ECRD) in Vienna / Austria, May 10-12, 2018.
International Symposium on “Accessibility to High-Value Medicines”
Now online available: Presentation on "Social Willingness to Pay” and the Case for “Social Cost Value Analysis" at the International Symposium on “Accessibility to High-Value Medicines” at the London School of Hygiene & Tropical Medicine in England, on December 6, 2017.
20th Annual European ISPOR Congress in Glasgow / Scotland, November 04 - 08, 2017
In addition to five scientific contributions on the current practice and the future of Health Technology Assessments (HTAs), alternatives to the logic of cost effectiveness, new European evidence on the economic value of a statistical life year, and the practice of pharmaceutical expenditure projections, Michael Schlander was interviewed by Cathy Jordan of GalbraithWight, answering questions on topical subjects and controversies in the field of health economics.